The largest database of trusted experimental protocols

Cobas amplicor ct ng pcr test

Manufactured by Roche
Sourced in United States

The Cobas Amplicor CT/NG PCR test is a laboratory diagnostic tool used for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections. It utilizes polymerase chain reaction (PCR) technology to amplify and detect the DNA of these organisms in clinical samples.

Automatically generated - may contain errors

2 protocols using cobas amplicor ct ng pcr test

1

STI Screening and Management in Uganda

Check if the same lab product or an alternative is used in the 5 most similar protocols
Testing for STIs was carried out at baseline and every 12 weeks thereafter for up to 2 years. Cervico-vaginal samples were collected by trained study doctors and tested at the research centre laboratory. Samples were tested for Trichomonas vaginalis (OSOM Trichomonas Test, Sekisui Diagnostics LLC, USA), Chlamydia trachomatis and Neisseria gonorrhoea (Cobas Amplicor CT/NG PCR test, Roche Diagnostic Systems, Branchburg, New Jersey, USA). Those who tested positive for STIs were treated following the Uganda national guidelines for syndromic management of STIs24 and the Centers for Disease Control and Prevention (CDC) treatment guidelines for aetiological diagnoses.25 (link)
+ Open protocol
+ Expand
2

HIV, Trichomoniasis, and Syphilis Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serial HIV-antibody rapid tests were done using Alere Determine™ HIV-1/2 (Alere Medical Co Ltd, Matsuhidai, Matsudo-shi, Chiba, Japan), followed by OraQuick-ADVANCE® Rapid HIV-1/2 Test (OraQuick-OraSure Technologies Inc, Pennsylvania, USA) to confirm a positive Determine result, with Uni-Gold™ HIV (Trinity Biotech, Ireland) as the tiebreaker. The tests were run by a laboratory technician. A participant was considered to be HIV positive if 2 antibody rapid tests showed positive results.
Additionally, cervico-vaginal samples were taken and tested for T. vaginalis (OSOM® Trichomonas Test, Sekisui Diagnostics LLC, USA) and C. trachomatis / N. gonorrhoeae (Cobas® Amplicor CT/NG PCR test, Roche Diagnostic Systems, Branchburg, New Jersey, USA), and blood samples were taken for syphilis testing using rapid plasma reagin (RPR)(Wampole® Impact RPR Test Kit, Alere™, Pennsylvania, USA). A positive RPR was confirmed using the Treponema pallidum particle agglutination assay (TPPA) (Serodia TP.PA, Fujirebio Inc, Pennsylvania, USA). A participant was reported to have syphilis if both the RPR and TPPA results were positive. Treatment was provided to those who tested positive for any STI according to the Centers for Disease Control and Prevention (CDC) STD treatment guidelines for 2010.[23 ]
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!